Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials

Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials

Submitted by admin on May 24, 2019 - 10:34am
Source: 
Pharmaceutical Business Review
News Tags: 
Novartis
QVM149
clinical trials
asthma
Headline: 
Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials
snippet: 

Novartis said that IND/GLY/MF (QVM149), a new inhaled combination treatment, showed significant improvements over current standard-of-care inhaled treatment and placebo in two phase 2 trials in patients with asthma.

Do Not Allow Advertisers to Use My Personal information